DOW vs PMCB · P/E 74, rev $42.96B vs $8.6M cap
Dow Inc (DOW) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
Dow Inc (DOW) is a chemicals company listed on US.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Latest reported DOW revenue for 2024-12-31 was $42.96B. Net income was $1.20B. Revenue was down 3.7% from 2023-12-31 to 2024-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
DOW currently screens at market cap $20.89B and trailing P/E 73.9. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the DOW and PMCB stock pages for the full models.
Not investment advice.